以端粒酶为靶标抗癌药物筛选模型建立及端粒酶抑制剂筛选

郑晓飞,王升启,孙志贤

中国生物化学与分子生物学报 ›› 2002, Vol. 18 ›› Issue (01) : 125-128.

PDF(202 KB)
PDF(202 KB)
中国生物化学与分子生物学报 ›› 2002, Vol. 18 ›› Issue (01) : 125-128.
论文

以端粒酶为靶标抗癌药物筛选模型建立及端粒酶抑制剂筛选

  • 郑晓飞,王升启,孙志贤
作者信息 +

Determination of Telomerase from HeLa Cells as a Target for Screening Antitumor Agents

  • ZHENG Xiao\|fei , WANG Sheng\|qi, SUN Zhi\|xian
Author information +
文章历史 +

Abstract

Telomerase, a ribonucleoprotein enzyme, has been found in immortalized but not in most somatic adult human tissues, and thus emerged as a novel target for cancer chemotherapy. Recently it has been found that telomerase is a fruitful target for oncologic drug development. A new method for screening antitumor agents by using telomerase as a target has been established according to the phenomena that the enzyme activity can be affected by some types of antitumor agents or chemicals. The telomerase was extracted from HeLa cells. The telomeric repeat amplification protocol(TRAP) was used to measure enzyme activity. Telomerase activity can be inhibited by 4 kinds of chemical compounds.

引用本文

导出引用
郑晓飞,王升启,孙志贤. 以端粒酶为靶标抗癌药物筛选模型建立及端粒酶抑制剂筛选[J]. 中国生物化学与分子生物学报, 2002, 18(01): 125-128
ZHENG Xiao\|fei , WANG Sheng\|qi, SUN Zhi\|xian. Determination of Telomerase from HeLa Cells as a Target for Screening Antitumor Agents[J]. Chinese Journal of Biochemistry and Molecular Biology, 2002, 18(01): 125-128

参考文献

1 KimNW ,PiatyszekMA ,ProwseKR ,HarleyCB ,WestMD ,HoPL ,CovielloGM ,WrightWE ,WeinrichSL ,ShayJW .Specificas sociationofhumantelomeraseactivitywithimmortalcellsandcancer.Science,1994,266(5193):2011~2015 2 ShayJW ,WrightWE .Telomeraseactivityinhumancancer.CurrOpinOncol,1996,8(1):66~71 3 郑晓飞,王升启,邢瑞云,朱宝珍,孙志贤.癌细胞株及胃癌组织端粒酶催化亚基基因表达研究.军事医学科学院院刊(ZhengXi ao fei,WangSheng qi,XingRui yun,ZhuBao zhen,SunZhi xian.HumantelomerasereversetranscriptaseRNAandtelomeraseactivityinmalignantcelllinesandgastrictumortissues.BullAcadMilMedSci),1999,23(3):190~192 4 郑晓飞,王升启,孙志贤.癌症治疗的目标———抑制端粒酶的策略.生物化学与生物物理进展(ZhengXiao fei,WangSheng qi,SunZhi xian.Atargetforcancertherapy:Strategiesfortelomeraseinh ibition.ProgBiochemBiophys),1998,25(3):242~245 5 NortonJC ,PiatyszekMA ,WrightWE ,ShayJW ,CoreyDR .Inhibi tionofhumantelomeraseactivitybypeptidenucleicacids.NatureBio tech,1996,14(5):615619 6 KanazawaY ,OhkawaK ,UedaK ,MitaE ,TakeharaT ,SasakiY ,KasaharaA ,HayashiN .Hammerheadribozyme mediatedinhibitionoftelomeraseactivityinextractsofhumanhepatocellularcarcinomacells.BiochemBiophysResCommun,1996,225(2):570~576 7 YegorovY ,ChernovDN ,AkimovSS ,BolshevaNL ,KrayevskyAA ,ZeleninAV .Reversetranscriptaseinhibitorssuppresstelomerasefunc tionandinducesenescence likeprocessesinculturedmousefibroblasts.FEBSLett,1996;389(2):115~118 8 StrahlC ,BlackburnEH .Effectsofreversetranscriptaseinhibitorsonte lomerelengthandtelomeraseavtivityintwoimmortalizedhumancelllines.MolCellBiol,1996,16(1):53~65 9 XuD ,GruberA ,PetersonC ,PisaP .SuppressionoftelomeraseactivityinHL60cellsaftertreatmentwithdifferentiatingagents.Leukemia,1996,10(8):1354~1357
PDF(202 KB)

108

Accesses

0

Citation

Detail

段落导航
相关文章

/